We also performed in vivo tumorigenicity assay by injecting 1000, 500, or 250 MDA‐MB‐231 NTC or ODC1/SRM knockdown subclone cells into SCID mice, and found that ODC1/SRM knockdown significantly decreased tumor‐initiating capacity (Figure 2K). The gene discussed is ODC1; the disease is neoplasm.